Palmitoylethanolamide reduces inflammation and itch in a mouse model of contact allergic dermatitis

European Journal of Pharmacology

Volumn 791, Issue , 2016, Pages 669-674

  Vaia, Massimo ^a   Petrosino, Stefania ^b,c,d   De Filippis, Daniele ^a   Negro, Luana ^a   Guarino, Andrea ^a   Carnuccio, Rosa ^a   Di Marzo, Vincenzo ^b,c   Iuvone, Teresa ^a,c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

^c Endocannabinoid Research Group   (Italy)

^d Epitech Group SpA   (Italy)

Author keywords

Angiogenesis; Contact allergic dermatitis (CAD); Dinitrofluorobenzene (DNFB); Itch; Mast cells (MCs); Palmitoylethanolamide (PEA)

Indexed keywords

1 FLUORO 2,4 DINITROBENZENE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; GW 6471; HORMONE RECEPTOR BLOCKING AGENT; PALMIDROL; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; ENDOCANNABINOID; ETHANOLAMINE DERIVATIVE; PALMITIC ACID DERIVATIVE; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL COUNT; CONTACT DERMATITIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG MECHANISM; DRUG RECEPTOR BINDING; EAR; FEMALE; INFLAMMATION; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PRURITUS; THICKNESS; TREATMENT OUTCOME; ANIMAL; C57BL MOUSE; COMPLICATION; CYTOLOGY; DERMATITIS, ALLERGIC CONTACT; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; IMMUNOLOGY; METABOLISM;

ANIMALS; CELL COUNT; DERMATITIS, ALLERGIC CONTACT; DINITROFLUOROBENZENE; DISEASE MODELS, ANIMAL; ENDOCANNABINOIDS; ETHANOLAMINES; FEMALE; GENE EXPRESSION REGULATION; INFLAMMATION; MAST CELLS; MICE; MICE, INBRED C57BL; PALMITIC ACIDS; PRURITUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84991388038     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2016.10.005     Document Type: Article

References (39)

1. Blázquez, C., Carracedo, A., Barrado, L., Real, P.J., Fernández-Luna, J.L., Velasco, G., Malumbres, M., Guzmán, M., Cannabinoid receptors as novel targets for the treatment of melanoma. FASEB J. 20 (2006), 2633–2635.
2. Cipriano, M., Esposito, G., Negro, L., Capoccia, E., Sarnelli, G., Scuderi, C., De Filippis, D., Steardo, L., Iuvone, T., Palmitoylethanolamide regulates production of pro-angiogenic mediators in a model of β amyloid-induced astrogliosis in vitro. CNS Neurol. Disord. Drug Targets 14 (2015), 828–837.
3. Colville-Nash, P.R., Alam, C.A., Appleton, I., Brown, J.R., Seed, M.P., Willoughby, D.A., The pharmacological modulation of angiogenesis in chronic granulomatous inflammation. J. Pharmacol. Exp. Ther. 274 (1995), 1463–1472.
4. D'Agostino, G., La Rana, G., Russo, R., Sasso, O., Iacono, A., Esposito, E., Raso, G.M., Cuzzocrea, S., Lo Verme, J., Piomelli, D., Meli, R., Calignano, A., Acute intracerebroventricular administration of palmitoylethanolamide, an endogenous peroxisome proliferator-activated receptor-alpha agonist, modulates carrageenan-induced paw edema in mice. J. Pharmacol. Exp. Ther. 322 (2007), 1137–1143.
5. De Filippis, D., Russo, A., D'Amico, A., Esposito, G., Pietropaolo, C., Cinelli, M., Russo, G., Iuvone, T., Cannabinoids reduce granuloma-associated angiogenesis in rats by controlling transcription and expression of mast cell protease-5. Br. J. Pharm. 154 (2008), 1672–1679.
6. De Filippis, D., D'Amico, A., Iuvone, T., Cannabinomimetic control of mast cell mediator release: new perspective in chronic inflammation. J. Neuroendocr. 20:1 (2008), 20–25.
7. Di Filippo, C., Rossi, F., Rossi, S., D'Amico, M., Cannabinoid CB2 receptor activation reduces mouse myocardial ischemia-reperfusion injury: involvement of cytokine/chemokines and PMN. J. Leukoc. Biol. 75 (2004), 453–459.
8. Esposito, E., Rinaldi, B., Mazzon, E., Donniacuo, M., Impellizzeri, D., Paterniti, I., Capuano, A., Bramanti, P., Cuzzocrea, S., Anti-inflammatory effect of simvastatin in an experimental model of spinal cord trauma: involvement of PPAR-α. J. Neuroinflamm., 9, 2012, 81.
9. Facci, L., Dal Toso, R., Romanello, S., Buriani, A., Skaper, S.D., Leon, A., Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc. Natl. Acad. Sci. USA 92 (1995), 3376–3380.
10. Guabiraba, R., Russo, R.C., Coelho, A.M., Ferreira, M.A., Lopes, G.A., Gomes, A.K., Andrade, S.P., Barcelos, L.S., Teixeira, M.M., Blockade of cannabinoid receptors reduces inflammation, leukocyte accumulation and neovascularization in a model of sponge-induced inflammatory angiogenesis. Inflamm. Res. 62 (2013), 811–821.
11. Horigome, K., Bullock, E.D., Johnson, E.M., Effects of nerve growth factor on rat peritoneal mast cells. Survival promotion and immediate-early gene induction. J. Biol. Chem. 269 (1994), 2695–2702.
12. Huang, H.C., Wang, S.S., Hsin, I.F., Chang, C.C., Lee, F.Y., Lin, H.C., Chuang, C.L., Lee, J.Y., Hsieh, H.G., Lee, S.D., Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats. Hepatology 56 (2012), 248–258.
13. Karsak, M., Gaffal, E., Date, R., Wang-Eckhardt, L., Rehnelt, J., Petrosino, S., Starowicz, K., Steuder, R., Schlicker, E., Cravatt, B., Mechoulam, R., Buettner, R., Werner, S., Di Marzo, V., Tüting, T., Zimmer, A., Attenuation of allergic contact dermatitis through the endocannabinoid system. Science 316 (2007), 1494–1497.
14. Khasabova, I.A., Xiong, Y., Coicou, L.G., Piomelli, D., Seybold, V., Peroxisome proliferator-activated receptor α mediates acute effects of palmitoylethanolamide on sensory neurons. J. Neurosci. 32 (2012), 12735–12743.
15. Kitagaki, H., Fujisawa, S., Watanabe, K., Hayakawa, K., Shiohara, T., Immediate-type hypersensitivity response followed by a late reaction is induced by repeated epicutaneous application of contact sensitizing agents in mice. J. Invest. Dermatol. 105 (1995), 749–755.
16. Kuraishi, Y., Nagasawa, T., Hayashi, K., Satoh, M., Scratching behavior induced by pruritogenic but not algesiogenic agents in mice. Eur. J. Pharmacol. 275 (1995), 229–233.
17. Leon, A., Buriani, A., Dal Toso, R., Fabris, M., Romanello, S., Aloe, L., Levi-Montalcini, R., Mast cells synthesize, store, and release nerve growth factor. Proc. Natl. Acad. Sci. USA 91 (1994), 3739–3743.
18. Lo Verme, J., Fu, J., Astarita, G., La Rana, G., Russo, R., Calignano, A., Piomelli, D., The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. Mol. Pharmacol. 67 (2005), 15–19.
19. Magerl, W., Westerman, R.A., Möhner, B., Handwerker, H.O., Properties of transdermal histamine iontophoresis: differential effects of season, gender, and body region. J. Invest. Dermatol. 94 (1990), 347–352.
20. Navi, D., Saegusa, J., Liu, F.T., Mast cells and immunological skin diseases. Clin. Rev. Allergy Immunol. 33 (2007), 144–155.
21. Noli, C., Della Valle, M.F., Miolo, A., Medori, C., Schievano, C., Efficacy of ultra-micronized palmitoylethanolamide in canine atopic dermatitis: an open-label multi-centre study. Vet. Dermatol, 2015, 10.1111/vde.12250 (Epub ahead of print).
22. Paus, R., Schmelz, M., Bíró, T., Steinhoff, M., Frontiers in pruritus research: scratching the brain for more effective itch therapy. J. Clin. Invest. 116 (2006), 1174–1186.
23. Petrosino, S., Iuvone, T., Di Marzo, V., N-palmitoyl-ethanolamine: biochemistry and new therapeutic opportunities. Biochimie 92 (2010), 724–727.
24. Petrosino, S., Cristino, L., Karsak, M., Gaffal, E., Ueda, N., Tüting, T. Bisogno, T., De, Filippis, D., D'Amico, A., Saturnino, C., Orlando, P., Zimmer, A., Iuvone, T., Protective role of palmitoylethanolamide in contact allergic dermatitis. (Di Marzo,6 V.) Allergy, 65, 2010, 698–711.
25. Petrosino, S., Schiano Moriello, A., Cerrato, S., Fusco, M., Puigdemont, A., De Petrocellis, L., Di Marzo, V., The anti-inflammatory mediator palmitoylethanolamide enhances the levels of 2-arachidonoyl-glycerol and potentiates its actions at TRPV1 cation channels. Br. J. Pharmacol. 173 (2016), 1154–1162.
26. Pisanti, S., Malfitano, A.M., Grimaldi, C., Santoro, A., Gazzerro, P., Laezza, C., Bifulco, M., Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents. Best. Pract. Res. Clin. Endocrinol. Metab. 23 (2009), 117–131.
27. Reichenbach, V., Ros, J., Fernández-Varo, G., Casals, G., Melgar-Lesmes, P., Campos, T., Makriyannis, A., Morales-Ruiz, M., Jiménez, W., Prevention of fibrosis progression in CCl4-treated rats: role of the hepatic endocannabinoid and apelin systems. J. Pharmacol. Exp. Ther. 340 (2012), 629–637.
28. Seike, M., Takata, T., Ikeda, M., Kodama, H., Terui, T., Ohtsu, H., Histamine helps development of eczematous lesions in experimental contact dermatitis in mice. Arch. Dermatol. Res 297 (2005), 68–74.
29. Simone, D.A., Ngeow, J.Y., Whitehouse, J., Becerra-Cabal, L., Putterman, G.J., La Motte, R.H., The magnitude and duration of itch produced by intracutaneous injections of histamine. Somatosens. Res. 5 (1987), 81–92.
30. Skaper, S.D., Facci, L., Giusti, P., Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator. Mol. Neurobiol. 48 (2013), 340–352.
31. Stucky, C.L., Koltzenburg, M., Schneider, M., Engle, M.G., Albers, K.M., Davis, B.M., Overexpression of nerve growth factor in skin selectively affects the survival and functional properties of iceptors. J. Neurosci. 19 (1999), 8509–8516.
32. Suto, H., Nakae, S., Kakurai, M., Sedgwick, J.D., Tsai, M., Galli, S.J., Mast cell-associated TNF promotes dendritic cell migration. J. Immunol. 176 (2006), 4102–4112.
33. Tachibana, T., Toda, K.I., Furukawa, F., Taniguchi, S., Imamura, S., Histamine metabolism in delayed type hypersensitivity comparative analysis with cellular infiltrates. Arch. Dermatol. Res. 282 (1990), 217–222.
34. Tron, V.A., Coughlin, M.D., Jang, D.E., Stanisz, J., Sauder, D.N., Expression and modulation of nerve growth factor in murine keratinocytes (PAM 212). J. Clin. Invest. 85 (1990), 1085–1089.
35. Watanabe, H., Mamelak, A.J., Wang, B., Howell, B.G., Freed, I., Esche, C., Nakayama, M., Nagasaki, G., Hicklin, D.J., Kerbel, R.S., Sauder, D.N., Anti-vascular endothelial growth factor receptor-2 (Flk-1/KDR) antibody suppresses contact hypersensitivity. Exp. Dermatol 13 (2004), 671–681.
36. Watanabe, N., Tomimori, Y., Saito, K., Miura, K., Wada, A., Tsudzuki, M., Fukuda, Y., Chymase inhibitor improves dermatitis in NC/Nga mice. Int. Arch. Allergy Immunol. 128 (2002), 229–234.
37. Wernersson, S., Pejler, G., Mast cell secretory granules: armed for battle. Nat. Rev. Immunol. 14 (2014), 478–494.
38. Yamamoto, A., Watanabe, H., Sueki, H., Nakanishi, T., Yasuhara, H., Iijima, M., Vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK 222584 inhibits both the induction and elicitation phases of contact hypersensitivity. J. Dermatol. 34 (2007), 419–429.
39. Yuan, C., Wang, X.M., Guichard, A., Tan, Y.M., Qian, C.Y., Yang, L.J., Humbert, P., N-palmitoylethanolamine and N-acetylethanolamine are effective in asteatotic eczema: results of a randomized, double-blind, controlled study in 60 patients. Clin. Interv. Aging 17 (2014), 1163–1169.